Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701102 · ClinicalTrials.gov registry record · NA
Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery
A NA study of Arthroscopic Knee Surgery, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT01701102: Completed NA study of Arthroscopic Knee Surgery, sponsored by Hospital for Special Surgery, New York.
NCT01701102 is a NA study of Arthroscopic Knee Surgery that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01701102, a NA study of Arthroscopic Knee Surgery, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
Prolonged motor block and delayed ability to walk are limitations of spinal anesthesia in ambulatory (same-day) surgery. This can be improved by lowering the dose of local anesthetic (a medication that, when injected around nerves, blocks nerve conduction, resulting in numbness and weakness) used in the spine, but too low a dose can result in an incomplete block (inadequate anesthesia) in some patients. There is evidence that adding a low dose of fentanyl, a narcotic, to mepivacaine enhances the anesthetic effect. The purpose of this study is to determine the lowest dose of mepivacaine, a local anesthetic, when combined with fentanyl, for which spinal anesthesia is adequate for ambulatory knee arthroscopy.
Primary Outcome
The time frame of the study for each patient only covers the period between time of surgery and time of discharge from the hospital, which is on the same day as the day of surgery
Conditions Studied
Interventions
- PROCEDURE Mepivacaine (24 mg) plus fentanyl
- PROCEDURE Mepivacaine (27 mg) plus fentanyl
- PROCEDURE Mepivacaine (30 mg) plus fentanyl
- PROCEDURE Mepivacaine
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01701102 record still lists
NCT01701102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Arthroscopic Knee Surgery appearing as the primary indexed condition, and to 4 interventions - of which Mepivacaine (24 mg) plus fentanyl is the first listed.
NCT01701102 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01701102 about?
NCT01701102 is a clinical study titled "Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery". Prolonged motor block and delayed ability to walk are limitations of spinal anesthesia in ambulatory (same-day) surgery. This can be improved by lowering the dose of local anesthetic (a medication that, when injected around nerves, blocks nerve conduction, resulting in numbness and weakness) used in...
What is the current status of trial NCT01701102?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2011-12. Estimated completion is 2013-12.
What conditions does trial NCT01701102 study?
This clinical trial studies the following conditions: Arthroscopic Knee Surgery.
What interventions are being tested in trial NCT01701102?
The interventions under investigation include: Mepivacaine (24 mg) plus fentanyl (PROCEDURE), Mepivacaine (27 mg) plus fentanyl (PROCEDURE), Mepivacaine (30 mg) plus fentanyl (PROCEDURE), Mepivacaine (PROCEDURE).
Who is sponsoring clinical trial NCT01701102?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01701102 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01701102's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia